Sernova Completes Oversubscribed Private Placement of $2,754,000
23 juil. 2018 06h00 HE
|
Sernova Corp
LONDON, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces it has completed a non-brokered private placement of $2.754 million, pursuant to which...
Sernova Announces $2,000,000 First Closing of Private Placement
16 juil. 2018 06h00 HE
|
Sernova Corp
Due to Oversubscription, Offering Increased to $2,700,000 THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.LONDON, Ontario,...
Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes
05 juil. 2018 06h00 HE
|
Sernova Corp
LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces that patient screening and recruitment has begun in its...
Sernova Announces $2 Million Private Placement Financing
26 juin 2018 06h00 HE
|
Sernova Corp
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. LONDON, Ontario, June 26, 2018 (GLOBE NEWSWIRE) -- Sernova Corp....
Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch Clinical Study
14 mai 2018 06h00 HE
|
Sernova Corp
LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), announces today it has received University of Chicago Institutional Review Board (IRB) approval...
Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator
08 mai 2018 06h00 HE
|
Sernova Corp
LONDON, Ontario, May 08, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), announces Dr. Piotr Witkowski, M.D., Ph.D., a leading expert in type 1 diabetes (T1D) and islet...
Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer
04 mai 2018 06h00 HE
|
Sernova Corp
LONDON, Ontario, May 04, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), announced shareholder approval of all management resolutions brought forward at the 2018 Annual...
Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Glucose Monitoring Systems
22 févr. 2018 06h00 HE
|
Sernova Corp
LONDON, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical stage company developing regenerative medicine technologies for the treatment of...
Sernova to Participate at the Biotech Showcase 2018 Healthcare Partnering Conference
05 janv. 2018 09h40 HE
|
Sernova Corp
LONDON, Ontario, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical stage regenerative medicine company, today announced that Dr. Philip Toleikis,...
Sernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 Diabetes
11 déc. 2017 06h00 HE
|
Sernova Corp
LONDON, Ontario, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a clinical stage company developing regenerative medicine technologies for the long-term...